India to Poland: Busulfan Export Trade Route
India has recorded 6 verified shipments of Busulfan exported to Poland, representing a combined trade value of $308.9K USD. This corridor is served by 3 active Indian exporters, with an average shipment value of $51.5K USD. The leading Indian exporter is INTAS PHARMACEUTICALS LTD, which accounts for 81% of total export value with 2 shipments worth $250.3K USD. On the buying side, ACCORD HEALTHCARE POLSKA SP Z O O is the largest importer in Poland with $250.3K USD in purchases. The top 3 suppliers — INTAS PHARMACEUTICALS LTD, INTAS PHARMACEUTICALS LIMITED, INTAS PHARMACEUTICALS LIMITED — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Poland Busulfan corridor is one of India's established pharmaceutical export routes, with 6 shipments documented worth a combined $308.9K USD. The route is dominated by INTAS PHARMACEUTICALS LTD, which alone accounts for roughly 81% of all export value, reflecting the consolidated nature of India's busulfan manufacturing sector.
Across 3 active suppliers, the average shipment value stands at $51.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 71% of all shipments, consistent with busulfan's non-urgent bulk-order profile.
Shipment activity peaks during July–September, with an average transit time of 30 days port-to-port. The route has recorded an annual growth rate of 21.2%, placing it at rank #19 among India's top busulfan export destinations globally.
On the import side, key buyers of Indian busulfan in Poland include ACCORD HEALTHCARE POLSKA SP Z O O, ACCORD HEALTHCARE POLSKA SP.Z.O.O., ACCORD HEALTHCARE POLSKA SP. Z.O.O. and 1 others. ACCORD HEALTHCARE POLSKA SP Z O O is the single largest importer with 2 shipments valued at $250.3K USD.
Route Characteristics
- Average transit30 days
- Peak seasonQ3
- Primary modeSea freight
- Top portMUNDRA SEA (INMUN1)
Market Position
- Global rank#19
- Annual growth+21.2%
- Demand growth+18.0%
- Regulatory ease72/100
Top 10 Indian Busulfan Exporters to Poland
Showing top 10 of 3 Indian suppliers exporting Busulfan to Poland, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | INTAS PHARMACEUTICALS LTD Avg $125.1K per shipment | 2 | $250.3K | 81.0% |
| 2 | INTAS PHARMACEUTICALS LIMITED Avg $17.8K per shipment | 2 | $35.7K | 11.6% |
| 3 | INTAS PHARMACEUTICALS LIMITED Avg $11.5K per shipment | 2 | $22.9K | 7.4% |
This table shows the top 10 of 3 Indian companies exporting busulfan to Poland, ranked by total trade value. The listed exporters are: INTAS PHARMACEUTICALS LTD, INTAS PHARMACEUTICALS LIMITED, INTAS PHARMACEUTICALS LIMITED . INTAS PHARMACEUTICALS LTD is the dominant supplier with 2 shipments worth $250.3K USD, giving it a 81% market share.
Top 10 Busulfan Importers in Poland
Showing top 10 of 4 known buyers in Poland receiving Busulfan shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian busulfan in Poland include ACCORD HEALTHCARE POLSKA SP Z O O, ACCORD HEALTHCARE POLSKA SP.Z.O.O., ACCORD HEALTHCARE POLSKA SP. Z.O.O. , ACCORD HEALTHCARE POLSKA SP. Z O.O.. The largest importer is ACCORD HEALTHCARE POLSKA SP Z O O, accounting for $250.3K USD across 2 shipments — representing 81% of all busulfan imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | ACCORD HEALTHCARE POLSKA SP Z O O | 2 | $250.3K | 81.0% |
| 2 | ACCORD HEALTHCARE POLSKA SP.Z.O.O. | 1 | $28.9K | 9.4% |
| 3 | ACCORD HEALTHCARE POLSKA SP. Z.O.O. | 2 | $22.9K | 7.4% |
| 4 | ACCORD HEALTHCARE POLSKA SP. Z O.O. | 1 | $6.8K | 2.2% |
Top 10 Busulfan Formulations Imported by Poland
Showing top 10 of 4 product formulations shipped on the India to Poland Busulfan route, ranked by trade value
Poland imports a wide range of busulfan formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — PHARMA DRUGS & MEDI BUSULFAN INJ,6MG/ML,10MLX1VACCORD-PL/RO AS PER DOCUMENT — accounts for $250.3K USD across 2 shipments. A total of 4 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | PHARMA DRUGS & MEDI BUSULFAN INJ,6MG/ML,10MLX1VACCORD-PL/RO AS PER DOCUMENT | 2 | $250.3K | 81.0% |
| 2 | PHARMA DRUGS & MEDI: BUSULFAN INJ,6MG/ML,10MLX1V(ACCORD-PL/RO 2945X1X1VIAL | 1 | $28.9K | 9.4% |
| 3 | PHARMA DRUGS & MEDI BUSULFAN INJ,6MG/ML, | 2 | $22.9K | 7.4% |
| 4 | PHARM DRUG&MED:BUSULFAN INJ,6MG/ML,10MLX1V(ACCORD-PL/RO)EACH MLCONTAINS: BUSULFAN PH EUR ....6MG | 1 | $6.8K | 2.2% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 71%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
MUNDRA SEA (INMUN1) handles the highest volume with 2 shipments. Transit time averages 30 days by sea.
Market Dynamics
India's busulfan exports to Poland are driven primarily by a handful of large-scale manufacturers. INTAS PHARMACEUTICALS LTD with 2 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 3 active exporters signals a competitive but concentrated market — buyers in Poland benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — INTAS PHARMACEUTICALS LTD, INTAS PHARMACEUTICALS LIMITED, INTAS PHARMACEUTICALS LIMITED — together account for 100% of total trade value on this route. The average shipment value of $51.5K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as pharma drugs & medi: busulfan inj,6mg/ml,10mlx1v(accord-pl/ro 2945x1x1vial and pharma drugs & medi busulfan inj,6mg/ml, , suggesting that buyers in Poland tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, ACCORD HEALTHCARE POLSKA SP Z O O is the largest importer with 2 shipments worth $250.3K USD — representing 81% of all busulfan imports from India on this route.
Route Statistics
- Trade Volume
- $308.9K
- Avg. Shipment
- $51.5K
- Suppliers
- 3
- Buyers
- 4
- Transit (Sea)
- ~30 days
- Annual Growth
- +21.2%
Other Busulfan Routes
Unlock the Full India to Poland Busulfan Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 6 shipments on this route.
Frequently Asked Questions — India to Poland Busulfan Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Busulfan to Poland?
The leading Indian exporters of Busulfan to Poland are INTAS PHARMACEUTICALS LTD, INTAS PHARMACEUTICALS LIMITED, INTAS PHARMACEUTICALS LIMITED . INTAS PHARMACEUTICALS LTD holds the largest market share at approximately 81% of total trade value on this route.
Q What is the total value of Busulfan exports from India to Poland?
India exports Busulfan to Poland worth approximately $308.9K USD across 6 recorded shipments. The average value per shipment is $51.5K USD.
Q Which ports does India use to ship Busulfan to Poland?
The most active port of origin is MUNDRA SEA (INMUN1) with 2 shipments. Indian exporters primarily use sea freight for this route, with 71% of shipments going by sea and 19% by air.
Q How long does shipping take from India to Poland for Busulfan?
The average transit time for Busulfan shipments from India to Poland is approximately 30 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during July–September.
Q Is the India to Poland Busulfan trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 21.2% with demand growth tracking at 18.0%. The route is ranked #19 among India's top Busulfan export destinations globally.
Q How many suppliers are active on the India to Poland Busulfan route?
There are currently 3 active Indian suppliers exporting Busulfan to Poland. The market is moderately concentrated with INTAS PHARMACEUTICALS LTD accounting for 81% of total shipment value.
Q Who are the main importers of Busulfan from India in Poland?
The leading importers of Indian Busulfan in Poland include ACCORD HEALTHCARE POLSKA SP Z O O, ACCORD HEALTHCARE POLSKA SP.Z.O.O., ACCORD HEALTHCARE POLSKA SP. Z.O.O. , ACCORD HEALTHCARE POLSKA SP. Z O.O.. ACCORD HEALTHCARE POLSKA SP Z O O is the largest buyer with 2 shipments worth $250.3K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Poland export trade corridor identified from Indian Customs (DGFT) records for Busulfan.
- 2.Supplier/Buyer Matching: 3 Indian exporters and 4 importers in Poland matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 6 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
6 Verified Shipments
3 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists